ABSTRACT
INTRODUCTION

44
Increasing clinical incidents of antibiotic resistant bacteria are a major global healthcare issue.
pneumoniae MGH 78578 which range in size from 3.4 to 175.9 kilobases (kb) while one and two 88 different plasmids have been sequenced from K. pneumoniae strains NTUH- K2044 and 342, 89 respectively (13,54).
91
Recent advances in DNA pyrosequencing or Next Generation Sequencing (NGS) technology 92 now facilitate the rapid determination of whole genome sequences from microbial species (36).
93
Here, we apply this technology to study the spectrum of genetic factors involved in K. 94 pneumoniae antibiotic resistance. We selected for whole genome sequencing, two K. 
MATERIALS AND METHODS
103
Bacteriological experiments. K. pneumoniae strains KpJH1 and Kp1162281 are clinical 104 isolates from the culture collection of GlaxoSmithKline (Collegeville, Pennsylvania, USA).
105
Minimal inhibitory concentrations (MICs) were determined using broth microdilution methods 106 according to Clinical and Laboratory Standards Institute guidelines (53). The MIC was the 107 lowest concentration of an antibacterial compound that showed no visible growth after 108 incubation at 37oC for 18 to 24 h, with a starting inoculum of ~5.5 X 10 5 CFU/ml. Genomic
133
Genes were initially identified by TBLASTN searches using two KpJH1 with unknown effects on fluoroquinolone susceptibility that might warrant further investigation.
495
The enhanced complement of efflux pumps relative to drug susceptible strains (Table 6) 
